Search

Search Constraints

You searched for: Author/Creator Uziel, Y.

Search Results

1. AB1182 Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis. (23rd January 2014)

2. FRI0454 UNDER DETECTION OF INTERSTITIAL LUNG DISEASE IN JUVENILE SYSTEMIC SCLEROSIS (JSSC) UTILIZING PULMONARY FUNCTION TESTS. RESULTS FROM THE JUVENILE SCLERODERMA INCEPTION COHORT. (2nd June 2020)

4. FRI0537 Update on the Juvenile Systemic Sclerosis Inception Cohort Www.Juvenile-Scleroderma.Com. (10th June 2014)

5. OP0180 Maintenance of Efficacy by Canakinumab Treatment in Systemic Juvenile Idiopathic Arthritis Patients. (10th June 2014)

6. OP0291 TOFACITINIB FOR THE TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: RESULTS OF A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY. (2nd June 2020)

7. OP0306 Is there a Difference in the Presentation of Diffuse and Limited Subtype of Juvenile Systemic Sclerois in Childhood? Results from the Juvenile Scleroderma Inception Cohorte. www.juvenilescleroderma.com. (9th June 2015)

8. OP0340 Evidence based recommendations for corticosteroid tapering/discontinuation in new onset juvenile dermatomyositis patients from the printo trial. (12th June 2018)

9. SAT0257 Update on The Juvenile Systemic Sclerosis Inception Cohort Project. Characteristics of The First 74 Patients at First Assessment. (15th July 2016)

10. SAT0522 Canakinumab Pharmacokinetics in Patients Younger Than 2 Years Old with Cryopyrin Associated Periodic Syndromes. (9th June 2015)